Skip to main content
NCBI home page
California Medicine logoLink to California Medicine
. 1969 Feb;110(2):139–150.

Current status of the management of patients with endocrine-sensitive tumors. II. Carcinoma of the prostate, endometrium, thyroid, kidney and miscellaneous tumors.

L G Crowley, S A Duwe
PMCID: PMC1503291  PMID: 4894628

Full text

PDF
139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON D. G. MANAGEMENT OF ADVANCED ENDOMETRIAL ADENOCARCINOMA WITH MEDROXYPROGESTERONE ACETATE. Am J Obstet Gynecol. 1965 May 1;92:87–99. doi: 10.1016/0002-9378(65)90108-0. [DOI] [PubMed] [Google Scholar]
  2. ATHERTON L. D., ATHERTON L. AGGRESSIVE SURGERY FOR CARCINOMA OF THE PROSTATE. J Urol. 1964 Mar;91:294–297. doi: 10.1016/S0022-5347(17)64111-9. [DOI] [PubMed] [Google Scholar]
  3. BAGSHAW M. A., KAPLAN H. S., SAGERMAN R. H. LINEAR ACCELERATOR SUPERVOLTAGE RADIOTHERAPY. VII. CARCINOMA OF THE PROSTATE. Radiology. 1965 Jul;85:121–129. doi: 10.1148/85.1.121. [DOI] [PubMed] [Google Scholar]
  4. BARNES A. C., ROTHCHILD I. Experimental use of intravenously administered progesterone in advanced cases of cervical carcinoma. Obstet Gynecol. 1953 Feb;1(2):147–155. [PubMed] [Google Scholar]
  5. BELT E., TURNER R. D. A study of 229 consecutive cases of total perineal prostatectomy for cancer of the prostate. J Urol. 1957 Jan;77(1):62–77. doi: 10.1016/S0022-5347(17)66523-6. [DOI] [PubMed] [Google Scholar]
  6. BENGTSSON G., ULLBERG S. THE AUTORADIOGRAPHIC DISTRIBUTION PATTERN AFTER ADMINISTRATION OF DIETHYLSTILBOESTROL COMPARED WITH THAT OF NATURAL OESTROGENS. Acta Endocrinol (Copenh) 1963 Aug;43:561–570. doi: 10.1530/acta.0.0430561. [DOI] [PubMed] [Google Scholar]
  7. BLACK B. M., KIRK T. A., Jr, WOOLNER L. B. Multicentricity of papillary adenocarcinoma of the thyroid: influence on treatment. J Clin Endocrinol Metab. 1960 Jan;20:130–135. doi: 10.1210/jcem-20-1-130. [DOI] [PubMed] [Google Scholar]
  8. BLOOM H. J., BAKER W. H., DUKES C. E., MITCHLEY B. C. HORMONE-DEPENDENT TUMOURS OF THE KIDNEY. II. EFFECT OF ENDOCRINE ABLATION PROCEDURES ON THE TRANSPLANTED OESTROGEN-INDUCED RENAL TUMOUR OF THE SYRIAN HAMSTER. Br J Cancer. 1963 Dec;17:646–656. doi: 10.1038/bjc.1963.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. BLOOM H. J., DUKES C. E., MITCHLEY B. C. HORMONE-DEPENDENT TUMOURS OF THE KIDNEY. I. THE OESTROGEN-INDUCED RENAL TUMOUR OF THE SYRIAN HAMSTER. HORMONE TREATMENT AND POSSIBLE RELATIONSHIP TO CARCINOMA OF THE KIDNEY IN MAN. Br J Cancer. 1963 Dec;17:611–645. doi: 10.1038/bjc.1963.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. BOOHER R. J., PACK G. T. Desmomas of the abdominal wall in children. Cancer. 1951 Sep;4(5):1052–1065. doi: 10.1002/1097-0142(195109)4:5<1052::aid-cncr2820040523>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  11. BULBROOK R. D., FRANKS L. M., GREENWOOD F. C. Hormone excretion in prostatic cancer: an attempt to correlate urinary hormone excretion and clinical state. Br J Cancer. 1959 Mar;13(1):45–58. doi: 10.1038/bjc.1959.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. BULBROOK R. D., FRANKS L. M., GREENWOOD F. C. Hormone excretion in prostatic cancer: the early and late effects of endocrine treatment on urinary oestrogens, 17-ketosteroids and 17-ketogenic steroids. Acta Endocrinol (Copenh) 1959 Aug;31:481–499. [PubMed] [Google Scholar]
  13. Bloom H. J. Cancer of the urogenital tract: kidney. The basis for hormonal therapy. JAMA. 1968 May 13;204(7):605–606. doi: 10.1001/jama.204.7.605. [DOI] [PubMed] [Google Scholar]
  14. Bucalossi P., Veronesi U., Cascinelli N., Buraggi G. L., Miserocchi E., Monfardini S. Pituitary ablation with 90-Y implant in advanced thyroid cancer. Cancer. 1967 May;20(5):724–726. doi: 10.1002/1097-0142(1967)20:5<724::aid-cncr2820200524>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  15. CIANFRANI T. Endometrial carcinoma after bilateral oophorectomy. Am J Obstet Gynecol. 1955 Jan;69(1):64–72. doi: 10.1016/s0002-9378(16)37912-1. [DOI] [PubMed] [Google Scholar]
  16. CRILE G., Jr The endocrine dependency of certain thyroid cancers and the danger that hypothyroidism may stimulate their growth. Cancer. 1957 Nov-Dec;10(6):1119–1137. doi: 10.1002/1097-0142(195711/12)10:6<1119::aid-cncr2820100607>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  17. CROWLEY L. G., MACDONALD I. DELALUTIN AND ESTROGENS FOR THE TREATMENT OF ADVANCED MAMMARY CARCINOMA IN THE POSTMENOPAUSAL WOMAN. Cancer. 1965 Apr;18:436–446. doi: 10.1002/1097-0142(196504)18:4<436::aid-cncr2820180407>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  18. Crile G., Jr Endocrine dependency of papillary carcinomas of the thyroid. JAMA. 1966 Feb 28;195(9):721–724. [PubMed] [Google Scholar]
  19. DAHN I., JONSSON N., LUNDH G. DESMOID TUMOURS. A SERIES OF 33 CASES. Acta Chir Scand. 1963 Oct;126:305–314. [PubMed] [Google Scholar]
  20. DUNCAN C. J., KISTNER R. W., MANSELL H. Suppression of ovulation by trip-anisyl chloroethylene (TACE). Obstet Gynecol. 1956 Oct;8(4):399–407. [PubMed] [Google Scholar]
  21. Dunn L. J., Bradbury J. T. Endocrine factors in endometrial carcinoma. A preliminary report. Am J Obstet Gynecol. 1967 Feb 15;97(4):465–471. doi: 10.1016/0002-9378(67)90558-3. [DOI] [PubMed] [Google Scholar]
  22. EMMETT J. L., GREENE L. F., PAPANTONIOU A. Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies. J Urol. 1960 Apr;83:471–484. doi: 10.1016/S0022-5347(17)65741-0. [DOI] [PubMed] [Google Scholar]
  23. Enzinger F. M., Shiraki M. Musculo-aponeurotic fibromatosis of the shoulder girdle (extra-abdominal desmoid). Analysis of thirty cases followed up for ten or more years. Cancer. 1967 Jul;20(7):1131–1140. doi: 10.1002/1097-0142(196707)20:7<1131::aid-cncr2820200716>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  24. FLOCKS R. H. CLINICAL CANCER OF THE PROSTATE: A STUDY OF 4,000 CASES. JAMA. 1965 Aug 16;193:559–562. doi: 10.1001/jama.1965.03090070009002. [DOI] [PubMed] [Google Scholar]
  25. FLOCKS R. H. INTERSTITIAL IRRADIATION THERAPY WITH A SOLUTION OF AU198 AS PART OF COMBINATION THERAPY FOR PROSTATIC CARCINOMA. J Nucl Med. 1964 Sep;5:691–705. [PubMed] [Google Scholar]
  26. GEORGE F. W., CARLTON C. E., Jr, DYKHUIZEN R. F., DILLON J. R. COBALT-60 TELECURIETHERAPY IN THE DEFINITIVE TREATMENT OF CARCINOMA OF THE PROSTATE: A PRELIMINARY REPORT. J Urol. 1965 Jan;93:102–109. doi: 10.1016/S0022-5347(17)63727-3. [DOI] [PubMed] [Google Scholar]
  27. GRIFFITHS C. T., TOMIC M., CRAIG J. M., KISTNER R. W. EFFECT OF PROGESTINS, ESTROGENS AND CASTRATION ON INDUCED ENDOMETRIAL CARCINOMA IN THE RABBIT. Surg Forum. 1963;14:399–401. [PubMed] [Google Scholar]
  28. GUSBERG S. B., KAPLAN A. L. PRECURSORS OF CORPUS CANCER. IV. ADENOMATOUS HYPERPLASIA AS STAGE O CARCINOMA OF THE ENDOMETRIUM. Am J Obstet Gynecol. 1963 Nov 1;87:662–678. [PubMed] [Google Scholar]
  29. Gusberg S. B. Hormone-dependence of endometrial cancer. Obstet Gynecol. 1967 Aug;30(2):287–293. [PubMed] [Google Scholar]
  30. HALL W. H., BIELSCHOWSKY F. The development of malignancy in experimentally-induced adenomata of the thyroid. Br J Cancer. 1949 Dec;3(4):534-41, 2 pl. doi: 10.1038/bjc.1949.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. HERTIG A. T., SOMMERS S. C. Genesis of endometrial carcinoma; study of prior biopsies. Cancer. 1949 Nov;2(6):946-56, illust. doi: 10.1002/1097-0142(194911)2:6<946::aid-cncr2820020603>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  32. Halnan K. E. The place of non-surgical methods in diagnosis and management, and the long-term value of treatment of thyroid cancer. Br J Surg. 1965 Oct;52(10):736–739. doi: 10.1002/bjs.1800521007. [DOI] [PubMed] [Google Scholar]
  33. Huggins C., Scott W. W. Bilateral Adrenalectomy in Prostatic Cancer: Clinical Features and Urinary Excretion of 17-Ketosteroids and Estrogen. Ann Surg. 1945 Dec;122(6):1031–1041. [PMC free article] [PubMed] [Google Scholar]
  34. JEWETT H. J. Radical perineal prostatectomy for carcinoma: an analysis of cases at Johns Hopkins Hospital, 1904-1954. J Am Med Assoc. 1954 Nov 13;156(11):1039–1041. doi: 10.1001/jama.1954.02950110001001. [DOI] [PubMed] [Google Scholar]
  35. JEWETT H. J. Treatment of early cancer of the prostate. JAMA. 1963 Feb 2;183:373–375. doi: 10.1001/jama.1963.63700050037023b. [DOI] [PubMed] [Google Scholar]
  36. JOLLES B. Progesterone in the treatment of advanced malignant tumours of breast, ovary and uterus. Br J Cancer. 1962 Jun;16:209–221. doi: 10.1038/bjc.1962.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. KELLEY R. M., BAKER W. H. Progestational agents in the treatment of carcinoma of the endometrium. N Engl J Med. 1961 Feb 2;264:216–222. doi: 10.1056/NEJM196102022640503. [DOI] [PubMed] [Google Scholar]
  38. KENNEDY B. J. A progestogen for treatment of advanced endometrial cancer. JAMA. 1963 Jun 8;184:758–761. doi: 10.1001/jama.1963.03700230058009. [DOI] [PubMed] [Google Scholar]
  39. KISTNER R. W. Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium. Cancer. 1959 Nov-Dec;12:1106–1122. doi: 10.1002/1097-0142(195911/12)12:6<1106::aid-cncr2820120607>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  40. Kelley R. M., Baker W. H. The role of progesterone in human endometrial cancer. Cancer Res. 1965 Aug;25(7):1190–1192. [PubMed] [Google Scholar]
  41. Kistner R. W., Griffiths C. T., Craig J. M. Use of progestational agents in the management of endometrial cancer. Cancer. 1965 Dec;18(12):1563–1579. doi: 10.1002/1097-0142(196512)18:12<1563::aid-cncr2820181208>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  42. LARSON J. A. Estrogens and endometrial carcinoma. Obstet Gynecol. 1954 May;3(5):551–572. [PubMed] [Google Scholar]
  43. MALOOF F., VICKERY A. L., RAPP B. An evaluation of various factors influencing the treatment of metastatic thyroid carcinoma with I 131. J Clin Endocrinol Metab. 1956 Jan;16(1):1–27. doi: 10.1210/jcem-16-1-1. [DOI] [PubMed] [Google Scholar]
  44. MEISSNER W. A., SOMMERS S. C., SHERMAN G. Endometrial hyperplasia, endometrial carcinoma, and endometriosis produced experimentally by estrogen. Cancer. 1957 May-Jun;10(3):500–509. doi: 10.1002/1097-0142(195705/06)10:3<500::aid-cncr2820100312>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  45. McINNES G. F. Effect of diethylstilbestrol on advanced carcinoma of the cervix; preliminary observations. Cancer. 1954 Sep;7(5):1029–1030. doi: 10.1002/1097-0142(195409)7:5<1029::aid-cncr2820070530>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  46. NESBIT R. M., BAUM W. C. Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases. J Am Med Assoc. 1950 Aug 12;143(15):1317–1320. doi: 10.1001/jama.1950.02910500019005. [DOI] [PubMed] [Google Scholar]
  47. NIEBURGS H. E. The effect of excessive doses of diethylstilbestrol on carcinoma of the cervix. Obstet Gynecol. 1953 Sep;2(3):213–229. [PubMed] [Google Scholar]
  48. PANOS T. C., POTH E. J. Desmoid tumor of the abdominal wall: use of prednisone to prevent recurrence in a child. Surgery. 1959 May;45(5):777–779. [PubMed] [Google Scholar]
  49. PURVES H. D., GRIESBACH W. E., KENNEDY T. H. Studies in experimental goitre: malignant change in a transplantable rat thyroid tumour. Br J Cancer. 1951 Sep;5(3):301–310. doi: 10.1038/bjc.1951.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Pellillo D. Proliferative stromatosis of the uterus with pulmonary metastases. Remission following treatment with a longacting synthetic progestin: a case report. Obstet Gynecol. 1968 Jan;31(1):33–39. doi: 10.1097/00006250-196801000-00005. [DOI] [PubMed] [Google Scholar]
  51. Peterson E. P. Endometrial carcinoma in young women. A clinical profile. Obstet Gynecol. 1968 May;31(5):702–707. doi: 10.1097/00006250-196805000-00018. [DOI] [PubMed] [Google Scholar]
  52. Prout G. R., Jr, Brewer W. R. Response of men with advanced prostatic carcinoma to exogenous administration of testosterone. Cancer. 1967 Nov;20(11):1871–1878. doi: 10.1002/1097-0142(196711)20:11<1871::aid-cncr2820201112>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  53. RUSSELL W. O., IBANEZ M. L., CLARK R. L., WHITE E. C. THYROID CARCINOMA. CLASSIFICATION, INTRAGLANDULAR DISSEMINATION, AND CLINICOPATHOLOGICAL STUDY BASED UPON WHOLE ORGAN SECTIONS OF 80 GLANDS. Cancer. 1963 Nov;16:1425–1460. doi: 10.1002/1097-0142(196311)16:11<1425::aid-cncr2820161106>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  54. RUSSFIELD A. B. Histology of the human hypophysis in thyroid disease-hypothyroidism, hyperthyroidism, and cancer. J Clin Endocrinol Metab. 1955 Nov;15(11):1393–1408. doi: 10.1210/jcem-15-11-1393. [DOI] [PubMed] [Google Scholar]
  55. SCOTT W. W. AN EVALUATION OF ENDOCRINE THERAPY PLUS RADICAL PERINEAL PROSTATECTOMY IN THE TREATMENT OF ADVANCED CARCINOMA OF THE PROSTATE. J Urol. 1964 Jan;91:97–102. doi: 10.1016/S0022-5347(17)64063-1. [DOI] [PubMed] [Google Scholar]
  56. STERN E., HOPKINS C. E., WEINER J. M., MARMORSTON J. HORMONE EXCRETION PATTERNS IN BREAST AND PROSTATE CANCER ARE ABNORMAL. Science. 1964 Aug 14;145(3633):716–719. doi: 10.1126/science.145.3633.716. [DOI] [PubMed] [Google Scholar]
  57. STRODE J. E. Desmoid tumors particularly as related to their surgical removal. Ann Surg. 1954 Mar;139(3):335–340. doi: 10.1097/00000658-195403000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Samuels M. L., Sullivan P., Howe C. D. Medroxyprogesterone acetate in the treatment of renal cell carcinoma (hypernephroma). Cancer. 1968 Sep;22(3):525–532. doi: 10.1002/1097-0142(196809)22:3<525::aid-cncr2820220306>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  59. Smith J. P., Rutledge F., Soffar S. W. Progestins in the treatment of patients with endometrial adenocarcinoma. Am J Obstet Gynecol. 1966 Apr 1;94(7):977–984. doi: 10.1016/0002-9378(66)90036-6. [DOI] [PubMed] [Google Scholar]
  60. VARGA A., HENRIKSEN E. Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometral carcinoma. Obstet Gynecol. 1961 Dec;18:658–672. [PubMed] [Google Scholar]
  61. VARGA A., HENRIKSEN E. EFFECT OF 17-ALPHA-HYDROXYPROGESTERONE 17-N-CAPROATE ON VARIOUS PELVIC MALIGNANCIES. Obstet Gynecol. 1964 Jan;23:51–62. [PubMed] [Google Scholar]
  62. VARGA A., HENRIKSEN E. URINARY EXCRETION ASSAYS OF PITUITARY LUTEINIZING HORMONE (LH) RELATED TO ENDOMETRIAL CARCINOMA. Obstet Gynecol. 1963 Aug;22:129–136. [PubMed] [Google Scholar]
  63. WEINERT S. D., MARKS L. J., CHUTE R., DOWD J. B. Evaluation of relationship between corticosteroid-induced adrenocortical suppression and clinical effectiveness of corticosteroid therapy in prostatic carcinoma. J Urol. 1960 Aug;84:396–401. doi: 10.1016/S0022-5347(17)65555-1. [DOI] [PubMed] [Google Scholar]
  64. WENTZ W. B. EFFECT OF A PROGESTATIONAL AGENT ON ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL CANCER. Obstet Gynecol. 1964 Sep;24:370–375. doi: 10.1097/00006250-196409000-00007. [DOI] [PubMed] [Google Scholar]
  65. Waterman E. A., Benson R. C. Medrogestone therapy in advanced endometrial adenocarcinoma. Obstet Gynecol. 1967 Nov;30(5):626–634. [PubMed] [Google Scholar]
  66. Wentz W. B. Treatment of persistent endometrial hyperplasia with progestins. Am J Obstet Gynecol. 1966 Dec 1;96(7):999–1004. doi: 10.1016/0002-9378(66)90447-9. [DOI] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES